Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks


Producing Clinically Actionable Reports

A discussion of current thinking of how to manage the challenges of producing a report a clinician can use and a molecular lab can be proud of. The session will focus on the data integration challenges associated with genomic instruments, Electronic Health Records (EHR), Tumor Board Reviews, state of the art clinical curation processes and much more. Thought leaders that are actively providing cutting edge services in the Precision Medicine market today will participate in a lively discussion about how best to incorporate all of the new information available to researchers, clinicians and patients in a scalable and cost effective way. Don’t miss this one.


Sean Sigmon, Director of Translational Medicine, Oracle's Health Sciences

Sean Sigmon is a Director of Translational Medicine for Oracle’s Health Sciences business focused on Personalized Medicine. Previously, Sean was VP of Sales and Business Development at Translational Software, a leading Pharmacogenetic (PGx) Reporting company. Read Full Bio


Don Rule, CEO & Founder, Translational Software

Don founded Translational Software® to accelerate the use of molecular diagnostics. Prior to this he had a 14 year career at Microsoft, holding a variety of roles in providing Internet access to MSN, pioneering Virtual Private Networking products. Read Full Bio

Shaun R. Opie, Ph.D., Chief Scientific Officer, Vantari Genetics

Shaun R. Opie, PhD is a co-founder and the chief scientific officer of Vantari Genetics, a CLIA and CAP certified molecular diagnostics company based in Irvine, CA.  Shaun earned his PhD in moleculargenetics from the University of Florida. Read Full Bio

Web Analytics